PCSK9 and peripheral arterial disease: In our previous research, we found that circulating endothelial progenitor cell dysfunction, the number of apoptotic circulating endothelial cells (ECs), and vasculoangiogenic and oxidative biomarkers were significantly correlated with PCSK9 levels in patients with PAD [12].